Na Zhang
Postdoctoral Scholar, Otolaryngology - Head & Neck Surgery
All Publications
-
Embryonic exposure of estrogen and BPA in zebrafish leads to ADHD-like and ASD-like phenotypes, respectively
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
2025; 137: 111293
Abstract
Exposure to the estrogenic pollutant bisphenol A (BPA) during pregnancy and early childhood is a risk factor for numerous neurodevelopmental and psychiatric disorders in humans. To understand why early BPA exposure is associated with attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD), we have analyzed a series of zebrafish behaviors, neurodevelopmental process, and gene expression profiles, after a moderate level of estrogen (17β-estradiol, E2, as a positive control) and BPA treatments during embryogenesis (2-48 h post fertilization). E2 exposure-caused hyperactivity was likely due to elevated expression of cyp19a1b since blocking aromatase activity rescued the defect. Furthermore, E2 exposure resulted in impulsive behaviors, perhaps due to a reduced expression of brain th (crucial for dopamine synthesis), resembling the ADHD phenotypes. However, the hyperactivity upon BPA exposure was due to a reduction of GABAergic neurons, particularly in the midbrain. BPA-exposed fish were less-social, with increased repetitive behaviors and escape rate (during strobe light stimulation), like the ASD phenotypes. Taking advantage of published single-cell and bulk RNA-sequencing data related to zebrafish BPA exposure, we uncovered that embryonic midbrain GABAergic neurons express less stmn1a upon BPA exposure. When stmn1a function was partially lost, 14-day post-fertilization larvae became less social, further stressing the ASD phenotype after BPA exposure. Upon embryonic E2 and BPA exposure, we have unexpectedly unveiled zebrafish ADHD-like and ASD-like phenotypes, respectively, suggesting that women of childbearing age should be cautious to use BPA and estrogen related products.
View details for DOI 10.1016/j.pnpbp.2025.111293
View details for Web of Science ID 001440667900001
View details for PubMedID 40020986